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CD10 expression in various grades and interfollicular infiltrates of follicular lymphoma (FL) has not been well documented. Immunohistochemical staining for CD10 (clone 56C6) was performed on paraffin-embedded tissue from 26 cases of classic FL. Negative or weak expression of CD10 was more frequent in grade III (5/6 [83%]) than in grade I FLs
Follicular lymphoma (FL) is one of the most common types of lymphomas in adults. The Revised European-American classification and the World Health Organization classification of malignant lymphomas are based on further understanding of B-lymphocyte biology, careful morphologic evaluation, and application of immunophenotypic and genetic techniques. 1, 2 As such, FL has been defined by a follicular (nodular) pattern of lymphocytic infiltrate composed of neoplastic lymphocytes of follicle center cell origin, with and without diffuse areas. In addition to a B-cell phenotype (CD19+, CD20+), one of the immunophenotypic characteristics of FL is CD10 expression in the neoplastic cells.
CD10 is a 90-to 110-kd monomeric integral membrane glycoprotein that is expressed in a variety of neoplastic and nonneoplastic cell types. 3, 4 Its expression has been recognized as a characteristic marker for follicle center cells and FL, although other lymphoproliferative disorders, such as acute lymphoblastic lymphoma/leukemia and Burkitt lymphoma, may show CD10 expression.
Previous studies of CD10 expression in FL have been done by frozen section tissue and fresh tissue suspensions using frozen tissue immunohistochemical analysis and flow cytometric (FC) analysis, respectively. 5-9 These methods do not permit detailed morphologic evaluation. Not surprisingly, the results of these studies show a wide variation (29% to 100%) of CD10 expression in FL. [5] [6] [7] [8] In addition, these studies do not provide information on the intensity of CD10 expression.
A monoclonal antibody to CD10 antigen (clone 56C6) has become available for detailed morphologic evaluation of CD10 expression in FL on paraffin sections. 10, 11 Preliminary studies have revealed that CD10 expression, as determined by this antibody, is a sensitive marker for FL. 12, 13 However, the spectrum of CD10 expression in various grades and in interfollicular infiltrates of FLs has not been well documented in those studies.
The main goal of the present study was to perform systematic morphologic evaluation of CD10 expression in various grades and in interfollicular infiltrates of FLs. The expression of CD10 by immunohistochemical analysis using paraffin sections was compared with that by FC analysis when FC analysis study results were available. We also evaluated bcl-2 expression by immunohistochemical analysis and correlated it with CD10 expression.
Materials and Methods
Cases
We retrieved 26 cases of FL (16 men, 10 women; age range, 33-87 years; mean, 56.7) from the files of the Department of Pathology, Medical College of Wisconsin, Milwaukee. The morphologic diagnosis of FL was reviewed and confirmed. The cases were classified into grade I, II, or III according to Berard criteria. 14 
Immunohistochemical Stains
Formalin-or Bouin-fixed, paraffin-embedded tissue was available for all cases. Paraffin sections were mounted on Fisherbrand/Plus Superfrost Precleaned slides (Fisher Scientific, Pittsburgh, PA), heated at 60°C for 30 minutes, deparaffinized, and rehydrated. The stains for CD10 (clone 56C6, Novocastra, Newcastle upon Tyne, England) and bcl-2 (clone 124, DAKO, Carpinteria, CA) were performed with the antigen retrieval techniques as follows: Slides were incubated for 30 minutes in 50:50 methanol peroxide, and the antigen was retrieved in citrate buffer, pH 6.0 (CD10), or EDTA buffer, pH 10.0 (bcl-2), for 30 minutes at 98°C and then cooled for 20 minutes. Nonspecific protein binding sites were blocked by serum for 5 minutes, and the primary antibody was added at different dilutions (1:50 for CD10 and 1:100 for bcl-2). All slides were stained using an automated immunostainer (DAKO). The slides were incubated for 15 minutes in labeled streptavidin-biotin (DAKO) for linking and labeled subsequently with diaminobenzidine chromogen. Appropriate positive and negative controls were used in all cases.
Interpretation of Staining Results
Expression of bcl-2 and CD10 was reviewed systematically by two of us (C.-C.C. and C.E.) independently. The intensity of staining was graded as follows: strongly positive if the positive staining could be recognized readily at low power (2× objective); moderately positive if positive staining could be recognized at intermediate power (10× objective) but not at low power; weakly positive if staining could be recognized only at high power (40× objective); or negative if staining could not be recognized even at high power.
Each case was evaluated to determine the intensity of CD10 and bcl-2 staining in the follicular areas. In addition, the degree of CD10 expression in interfollicular infiltrates was particularly evaluated. The bcl-2-positive T cells were used as a positive internal control, and all sections that were negative for CD10, bcl-2, or both showed the presence of scattered bcl-2-positive T cells. This grading system led to agreement between the 2 observers for more than 95% of staining results. In the case of discrepant results, the 2 observers reevaluated the slide and eventually reached a consensus.
FC Analysis
Fresh tissue from the lymph nodes was washed once with RPMI and suspended at a cell concentration of 2.0 × 10 6 cells per milliliter. Two hundred microliters of the cell suspension was incubated with an adequate amount of each antibody for 30 minutes at room temperature. To determine CD10 expression in B cells, a combination of CD10-fluorescein isothiocyanate (clone W8E7, Becton Dickinson, San Jose, CA), CD19-phycoerythrin-Cy5 (clone J4-119, Immunotech, Beckman Coulter, Marseilles, France), and CD20-phycoerythrin (clone L2, Becton Dickinson) was used. FC analysis was performed on a flow cytometer (FACScan, Becton Dickinson). The data were collected in list mode, and analysis was done using CELLQuest software (Becton Dickinson).
CD10 expression was considered positive when present on at least 20% of the CD19+ cells. The fluorescence intensity (determined by mean fluorescence channel number) of CD10 then was compared with that of CD20. We defined CD10 expression as weak if the fluorescence intensity of CD10 was less than that of CD20 and as moderate to strong if the fluorescence intensity of CD10 was equal to that of CD20.
Results
The cases studied included 15 grade I, 5 grade II, and 6 grade III FLs ❚Table 1❚. Of 26 cases, FC analysis data were available for 16 cases for comparison with the immunohistochemical analysis results (Table 1) .
Our results revealed that CD10 was positive in 20 (77%) of 26 cases studied regardless of staining intensity (Table 1) by immunohistochemical analysis. In 20 (77%) of 26 cases, bcl-2 expression also was present, although expression did not completely correspond to CD10 expression. Of 26 cases, 23 (88%) were positive for either CD10 or bcl-2 (Table 1) . © American Society of Clinical Pathologists Only 3 cases (12%) were negative for both CD10 and bcl-2 (Table 1) . No differences in CD10 or bcl-2 expression were noted between specimens fixed in formalin or in Bouin solution ❚Table 2❚.
We further analyzed all cases for the intensity of CD10 and bcl-2 expression in the follicular areas among different grades of FL. The results showed that the intensity of CD10 and bcl-2 expression in the follicular areas was significantly stronger in grade I FLs than in grade III FLs (P < .05 for both; Mann-Whitney test) ( Table 1 ) ❚Figure 1❚ and ❚Figure 2❚. There were no significant differences in expression between grades I and II (Mann-Whitney test). The intensity of expression in grade II tended to be stronger than that in grade III; however, the difference was not statistically significant (P < .25; Mann-Whitney test).
In addition, negative or weak CD10 expression in the follicular areas was more frequently seen in grade III (5/6 [83%]) compared with grade I FLs (3/15 [20%]) (P < .03, chi-square) ( Figure 1, Table 1 ). This difference was not present between grade I and II or between grade II and III FLs. Similarly, negative or weak expression of bcl-2 was more frequent in grade III (3/6 [50%]) than in grade I FLs (3/15 [20%]); however, the difference was not statistically significant (P = .17, chi-square) ( Figure 2 , Table 1 ).
In some cases, the staining intensities were different between the follicular areas and the interfollicular infiltrates 
Discussion
CD10 expression by immunohistochemical analysis on paraffin-embedded tissue has been shown to be a sensitive marker for FL. 12, 13 However, CD10 expression in various grades and interfollicular infiltrates of FLs has not been well documented.
Our results show that the intensity of CD10 and bcl-2 expression is significantly different in different grades of FL. Expression of both CD10 and bcl-2 was significantly stronger in grade I FLs than in grade III FLs. In addition, negative or weak expression of CD10 was observed more frequently in grade III than in grade I FLs. The mechanism of the different intensity of CD10 expression observed in different grades of FL remains uncertain. However, the trend of decreasing CD10 expression in higher grades of FL seems similar (parallel) to the decreasing frequency of t(14;18) in higher grade FLs as previously reported. 1 Previous studies using FC analysis showed that CD10 expression correlated better with t(14;18) than bcl-2 expression by immunohistochemical analysis. 15 Thus, it is possible that the decrease of CD10 expression in higher grades of FL may be related to the lower frequency of t(14;18) in the higher grades of FL.
Furthermore, our results show that intensity of CD10 expression may be different in the follicular areas and in the interfollicular infiltrates in the same section. Six (38%) of 16 cases showed strong or moderate CD10 expression in follicular areas and weak or negative expression in interfollicular infiltrates. The mechanism is unknown. We speculate that the follicular microenvironment may enhance the follicle center cells to express CD10.
These findings also suggest that lack of CD10 expression in diffuse large B-cell lymphomas (DLBCLs) does not exclude the possibility that the neoplastic lymphocytes are of follicle center cell origin. CD10 expression has been shown in 20% to 34% of DLBCLs and has been used to support a subset of DLBCLs arising from FLs or from follicle center cells. 15 Our results may argue against subclassifying DLBCL based on CD10 expression as a marker for follicle center cell origin. 16 Additional markers such as bcl-6 and hMSH should be evaluated to determine whether DLBCLs are of follicle center cell origin. [17] [18] [19] King et al 20 reported that bcl-6 was expressed in all grades of FL but not in all cases of DLBCL. Although it was beyond the scope of the present study, it would be valuable to study bcl-6 expression intensity in different grades of FL in a manner similar to that used in the present study.
In some cases of FL, CD10 would seem useful for determining the spilling over of neoplastic follicle center cells into the interfollicular areas. Dogan et al 19 reported that expression of CD10 in interfollicular infiltrates favors a diagnosis of FL over reactive follicular hyperplasia. Our results further indicate that presence of CD10+ interfollicular infiltrates is particularly important in cases lacking expression of bcl-2 for supporting a diagnosis of FL, such as 3 cases in the present study (18, 24 , and 25).
Our finding that CD10 expression frequently is weak or negative in grade III and in interfollicular infiltrates of FLs raises the concern of interpreting CD10 expression using fine-needle aspiration (FNA) or core needle biopsy specimens. Sampling from the interfollicular infiltrates or grade III FLs may lead to incorrect classification of lymphoproliferative disorders. Some study results have suggested that FNA may be used as the primary diagnostic procedure with the support of immunophenotyping by FC or immunohistochemical analysis. 21, 22 Our observation provides the evidence that such a procedure should be used with caution and supports the importance of correlation of morphologic features with the immunophenotype.
Immunohistochemical analysis seems to be a more sensitive method than FC analysis for evaluating the CD10 expression; however, the difference is not statistically significant. Kurtin et al 12 showed similar results. They suggested that the difference may result from immunohistochemical analysis detecting cytoplasmic and surface CD10 but FC analysis detecting only surface CD10. 12 Our results as demonstrated by case 5 further suggest that the sampling of interfollicular infiltrates might lead to false negativity by FC analysis. This may be another mechanism that might lead to the discrepancies in CD10 expression between FC analysis and immunohistochemical analysis. Finally, CD10 expression by immunohistochemical analysis has the advantage, over FC analysis, of correlating morphologic features with immunophenotype. Our preliminary observations suggest that CD10+ lymphocytic infiltrate by immunohistochemical analysis in bone marrow is highly consistent with involvement by FL.
CD10 expression frequently is weak to negative in grade III and interfollicular infiltrates of FLs. Therefore, lack of CD10 expression in small specimens, such as needle core biopsy and FNA specimens, does not preclude the possibility of a diagnosis of FL. Furthermore, lack of CD10 expression in DLBCL does not exclude the possibility that the neoplastic lymphocytes are of follicle center origin. Immunohistochemical analysis for CD10 is of value to highlight spilling over of neoplastic follicle center cells into the
